[go: up one dir, main page]

FI932552L - Foerfarande foer framstaellning av en fast enhet doseringsform foer reglerad utloesningen - Google Patents

Foerfarande foer framstaellning av en fast enhet doseringsform foer reglerad utloesningen Download PDF

Info

Publication number
FI932552L
FI932552L FI932552A FI932552A FI932552L FI 932552 L FI932552 L FI 932552L FI 932552 A FI932552 A FI 932552A FI 932552 A FI932552 A FI 932552A FI 932552 L FI932552 L FI 932552L
Authority
FI
Finland
Prior art keywords
foer
reglerad
hutesningen
doseringsform
enhet
Prior art date
Application number
FI932552A
Other languages
English (en)
Other versions
FI932552A7 (fi
FI932552A0 (fi
Inventor
Per Johan Gunnar Lundberg
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of FI932552A7 publication Critical patent/FI932552A7/fi
Publication of FI932552A0 publication Critical patent/FI932552A0/fi
Publication of FI932552L publication Critical patent/FI932552L/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Control Of Vending Devices And Auxiliary Devices For Vending Devices (AREA)
  • Compositions Of Oxide Ceramics (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
FI932552A 1990-12-07 1991-12-03 Foerfarande foer framstaellning av en fast enhet doseringsform foer reglerad utloesningen FI932552L (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9003904A SE9003904D0 (sv) 1990-12-07 1990-12-07 Method for the manufacture of a pharmaceutical dosage form
PCT/SE1991/000813 WO1992010169A1 (en) 1990-12-07 1991-12-03 Method for the manufacture of a controlled release solid unit dosage form

Publications (3)

Publication Number Publication Date
FI932552A7 FI932552A7 (fi) 1993-06-04
FI932552A0 FI932552A0 (fi) 1993-06-04
FI932552L true FI932552L (fi) 1993-06-04

Family

ID=20381123

Family Applications (1)

Application Number Title Priority Date Filing Date
FI932552A FI932552L (fi) 1990-12-07 1991-12-03 Foerfarande foer framstaellning av en fast enhet doseringsform foer reglerad utloesningen

Country Status (20)

Country Link
US (1) US5419918A (fi)
EP (1) EP0560822B1 (fi)
JP (1) JP3239319B2 (fi)
AT (1) ATE130188T1 (fi)
AU (1) AU659114B2 (fi)
CA (1) CA2097175A1 (fi)
DE (1) DE69114721T2 (fi)
DK (1) DK0560822T3 (fi)
ES (1) ES2079689T3 (fi)
FI (1) FI932552L (fi)
GR (1) GR3018685T3 (fi)
HU (1) HUT64212A (fi)
IE (1) IE914229A1 (fi)
IS (1) IS3789A7 (fi)
NO (1) NO932054D0 (fi)
PL (1) PL168605B1 (fi)
PT (1) PT99721A (fi)
SE (1) SE9003904D0 (fi)
WO (1) WO1992010169A1 (fi)
YU (1) YU182091A (fi)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ291495B6 (cs) * 1992-09-18 2003-03-12 Yamanouchi Pharmaceutical Co., Ltd. Hydrogelotvorný farmaceutický přípravek s prodlouženým uvolňováním
JP3598049B2 (ja) * 1992-09-18 2004-12-08 山之内製薬株式会社 ハイドロゲル徐放性製剤
ES2059260B1 (es) * 1992-10-06 1995-04-16 Espanola Prod Quimicos Procedimiento de preparacion de comprimidos conteniendo diclofenaco; dispersables en agua.
US5393765A (en) * 1993-12-13 1995-02-28 Hoffmann-La Roche Inc. Pharmaceutical compositions with constant erosion volume for zero order controlled release
US5948437A (en) * 1996-05-23 1999-09-07 Zeneca Limited Pharmaceutical compositions using thiazepine
IN186245B (fi) 1997-09-19 2001-07-14 Ranbaxy Lab Ltd
JP2000034224A (ja) * 1998-05-11 2000-02-02 Freunt Ind Co Ltd 徐放性錠剤、その添加剤組成物及びそれらの製造方法
US6368625B1 (en) 1998-08-12 2002-04-09 Cima Labs Inc. Orally disintegrable tablet forming a viscous slurry
US6214381B1 (en) 1998-09-08 2001-04-10 Effcon, Inc. Methazolamide composition and method of use
WO2003011256A1 (en) * 2001-07-30 2003-02-13 Sun Pharmaceutical Industries Limited Oral controlled release pharmaceutical composition of a prokinetic agent
US20030068375A1 (en) 2001-08-06 2003-04-10 Curtis Wright Pharmaceutical formulation containing gelling agent
US20040185093A1 (en) * 2003-03-18 2004-09-23 Szymczak Christopher E. Compositions containing sucralose
US20060062811A1 (en) * 2004-09-21 2006-03-23 Szymczak Christopher E Medicinal cooling emulsions
SA07280459B1 (ar) 2006-08-25 2011-07-20 بيورديو فارما إل. بي. أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني
CA2909370A1 (en) * 2013-04-16 2014-10-23 Murray And Poole Enterprises Limited Sustained-release formulations of colchicine and methods of using same
US9980946B1 (en) 2017-01-25 2018-05-29 Effcon Laboratories, Inc. Extended release methazolamide formulation
JP7426685B2 (ja) * 2018-06-14 2024-02-02 株式会社東洋新薬 錠剤

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4369172A (en) * 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
FR2525474A1 (fr) * 1982-04-26 1983-10-28 Roussel Uclaf Nouvelle forme pharmaceutique orale de clometacine
EP0149186B1 (en) * 1983-12-20 1988-03-16 Tosoh Corporation Process for preventing agglomeration of powders
US4795327A (en) * 1984-03-26 1989-01-03 Forest Laboratories, Inc. Controlled release solid drug dosage forms based on mixtures of water soluble nonionic cellulose ethers and anionic surfactants
EP0294493A4 (en) * 1986-12-25 1989-07-24 Teysan Pharmaceuticals Co Ltd SLOW DISSOLUTION GRANULE AND COMPOSITE GRANULE WITH PERSISTENT EFFECT PREPARED FROM THE FIRST GRANULE.
US4786503A (en) * 1987-04-06 1988-11-22 Alza Corporation Dosage form comprising parallel lamine
US4971805A (en) * 1987-12-23 1990-11-20 Teysan Pharmaceuticals Co., Ltd. Slow-releasing granules and long acting mixed granules comprising the same
US5024842A (en) * 1988-04-28 1991-06-18 Alza Corporation Annealed coats
CA2002492A1 (en) * 1988-11-11 1990-05-11 Sandra T. A. Malkowska Pharmaceutical ion exchange resin composition

Also Published As

Publication number Publication date
DE69114721T2 (de) 1996-04-18
WO1992010169A1 (en) 1992-06-25
FI932552A7 (fi) 1993-06-04
HU9301672D0 (en) 1993-09-28
YU182091A (sh) 1994-04-05
FI932552A0 (fi) 1993-06-04
PL299376A1 (en) 1994-03-07
JP3239319B2 (ja) 2001-12-17
HUT64212A (en) 1993-12-28
EP0560822B1 (en) 1995-11-15
CA2097175A1 (en) 1992-06-08
AU659114B2 (en) 1995-05-11
PL168605B1 (pl) 1996-03-29
EP0560822A1 (en) 1993-09-22
JPH06503310A (ja) 1994-04-14
DE69114721D1 (de) 1995-12-21
GR3018685T3 (en) 1996-04-30
NO932054L (no) 1993-06-04
IE914229A1 (en) 1992-06-17
ES2079689T3 (es) 1996-01-16
AU8930991A (en) 1992-07-08
IS3789A7 (is) 1992-06-08
US5419918A (en) 1995-05-30
SE9003904D0 (sv) 1990-12-07
NO932054D0 (no) 1993-06-04
PT99721A (pt) 1993-04-30
ATE130188T1 (de) 1995-12-15
DK0560822T3 (da) 1996-03-11

Similar Documents

Publication Publication Date Title
FI930862L (fi) En doseringsform foer tidsvarierande moenster av laekemedeloeverlaotelse
FI930886L (fi) Foerfarande foer hindrande av avstoetning av transplanterad vaevnad
FI930848A0 (fi) Foerfarande foer separering av ilmenit
FI923931L (fi) Anordning foer granskning av insidan av en foergrenad roerlinje
FI930736L (fi) Foerfarande foer framstaellning av ramnos fraon ramnolipider
FI932761L (fi) Foerfarande foer framstaellning av aktiva substanser innehaollande mikropartiklar av hydrolytiskt nedbrytbara polymerer
FI930763A7 (fi) Framstaellning av klordioxid fraon klorsyra
FI930165A0 (fi) Framstaellning av synnerligen aktiva tvaettmedelspartiklar
FI925884A7 (fi) Avlaegsning av signaldistorsion
FI924569L (fi) Foerfarande foer enantioselektiv framstaellning av fenylisoserinderivat
FI924568L (fi) Foerfarande foer stereoselektiv framstaellning av fenylisoserinderivat
FI925415L (fi) Framstaellning av substituerade piperidiner
FI925988L (fi) Foerfarande foer framstaellning av b-laktamer
FI925515L (fi) Foerfarande foer framstaellning av alfa-2-interferonkristaller
FI925435A7 (fi) Foerfarande foer beredning av en vattenloesning av natriumfoereningar
FI931644A7 (fi) Foerfarande foer framstaellning av nodulaert gjutjaern
FI924436A7 (fi) Foerfarande foer tillverkning av expanderade polystyrenfolier
FI932552L (fi) Foerfarande foer framstaellning av en fast enhet doseringsform foer reglerad utloesningen
FI925805L (fi) Framstaellning av kompositmaterial
FI924826L (fi) Fettkompositioner innehaollande polyestrar av polyolfettsyror
FI925609A0 (fi) Foerfarande foer framstaellning av sykliska sulfater
FI932904A7 (fi) Foerfarande foer framstaellning av substituerade bensofuranderivat
FI931879A7 (fi) Framstaellning av en peroxosyra
FI924374L (fi) Foerfarande foer dubbelsidig belaeggning av en roerlig materialbana
FI923776A7 (fi) Foerfarande foer formning av pappersark

Legal Events

Date Code Title Description
FD Application lapsed